Clinical trials in Hong Kong
4,796 studies list at least one site in Hong Kong. 1,212 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Hong Kong recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Chinese University of Hong Kong (1,127) · The University of Hong Kong (985) · The Hong Kong Polytechnic University (477) · Novartis Pharmaceuticals (150) · Hoffmann-La Roche (140) · AstraZeneca (95) · GlaxoSmithKline (83) · Pfizer (73)
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting21
- A Mechanism Randomised Controlled Trial of a Three-Agent LLM-Augmented mHealth Intervention for Late-Life Loneliness in Older AdultsNov 10, 2026NCT07822828
- WATER IV PCa (AS Sub-study)Nov 6, 2026NCT07650448
- Comprehensive Clinical Prediction Rule for Acute Heart FailureNov 5, 2026NCT07754084
- Effects of Pulsed Electromagnetic Field Therapy on Meniscal Healing, Symptom Relief, and Knee FunctionNov 4, 2026NCT07117929
- A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With MenNov 4, 2026NCT07472582
Show 16 moreShow fewer
- Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral FrailtyNov 3, 2026NCT07733726
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRIOct 27, 2026NCT07386496
- Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial CarcinomaOct 27, 2026NCT07557563
- Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBCOct 27, 2026NCT07724886
- Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)Oct 27, 2026NCT07728071
- [11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept StudyOct 26, 2026NCT07814105
- Butyrate and Taurine for Chronic Postsurgical Pain in Adult Cardiac Surgical PatientsOct 22, 2026NCT07144033
- Thoracic Surgery by SHURUI Single-Port Surgical RobotOct 22, 2026NCT07255703
- Belzutifan VHL RCC HK Prospective RegistryOct 22, 2026NCT07554508
- Myofunctional Therapy for Children With OSAOct 21, 2026NCT07249944
- A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPDOct 21, 2026NCT07344285
- Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)Oct 21, 2026NCT07351357
- Aortic Dissection Detection Risk Score With D-dimer to Rule-Out Acute Aortic SyndromeOct 21, 2026NCT07640334
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionOct 13, 2026NCT07128199
First site in Hong Kong13
- A Mechanism Randomised Controlled Trial of a Three-Agent LLM-Augmented mHealth Intervention for Late-Life Loneliness in Older AdultsNov 10, 2026NCT07822828
- A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With MenNov 4, 2026NCT07472582
- Virtual Reality for Mental Well-being in Older People With Physical DisabilitiesNov 3, 2026NCT05818579
- E-health Brisk Walking in Older People With Cognitive FrailtyNov 2, 2026NCT05758740
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisOct 28, 2026NCT06632444
Show 8 moreShow fewer
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisOct 28, 2026NCT06632457
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Oct 28, 2026NCT06823115
- A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)Oct 26, 2026NCT06174987
- Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service EvaluationOct 22, 2026NCT06808555
- Prevail Global StudyOct 21, 2026NCT06535854
- A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPDOct 21, 2026NCT07344285
- Mhealth Social Support for People at Risk of Metabolic SyndromeOct 16, 2026NCT06169943
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
Results posted12
- Pegcetacoplan Long Term Safety and Efficacy Extension StudyNov 10, 2026NCT03531255
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
- Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the InvestigatorOct 29, 2026NCT01742299
- Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate CancerOct 29, 2026NCT03367702
Show 7 moreShow fewer
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisOct 28, 2026NCT05809934
- Geriatric Hip Fractures Caregiver ProgrammeOct 23, 2026NCT05393349
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)Oct 16, 2026NCT03310125
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerOct 14, 2026NCT05337137
Stopped7
- Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer SurgeryTerminatedNov 6, 2026NCT04933266
- Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerTerminatedNov 6, 2026NCT05132075
- Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant CultureTerminatedOct 30, 2026NCT05375006
- Fecal Microbiota Transplantation for Patients With Chronic Widespread PainWithdrawnOct 30, 2026NCT05700331
- Incidence and Risk Factors for Persistent Post-sternotomy Pain After Cardiac Surgery in Local Chinese Population: a Prospective Cohort StudySuspendedOct 22, 2026NCT04644666
Show 2 moreShow fewer
- Multiomics Biomarkers for UrolithiasisTerminatedOct 22, 2026NCT05452291
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedOct 15, 2026NCT05268289
Newly registered21
- A Nurse-led Structured Risk Factor Management Programme to Improve Quality of Life for Patients With Atrial FibrillationNov 10, 2026NCT07929259
- Exercise to Improve Heart and Metabolic Health After Childbirth in Women at High Risk for PreeclampsiaNov 6, 2026NCT07921173
- Multi-center Study of Three-Dimensional Transesophageal Echocardiography in Patients With Secondary Mitral RegurgitationNov 5, 2026NCT07918937
- Pilot Project on Enhancing Support for Hidden Elderly in the Three-nil Buildings and Old Tenement Buildings: Capacity Building & Impact EvaluationNov 5, 2026NCT07920328
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
Show 16 moreShow fewer
- Wearable Device Guided Exercise for Patients on Total Knee Arthroplasty Wait-listNov 3, 2026NCT07912333
- One Inch Punch High Impact Training Randomized Control Trial (1'' Punch HIT RCT)Nov 3, 2026NCT07913945
- Effectiveness of Internet-based Unified Protocol (iUP) for Emotional Problems: A Randomized Controlled TrialNov 2, 2026NCT07908628
- Ultrasound-guided Microwave Ablation of Benign Thyroid NodulesOct 30, 2026NCT07906821
- The Role of ERBT Plus Adjuvant Intravesical Induction and Maintenance Chemotherapy for Intermediate-Risk NMIBCOct 30, 2026NCT07907575
- Hybrid mHealth for Low Back PainOct 29, 2026NCT07902778
- Diagnostic Accuracy, Clinical Utility and Implementation of Point-of-Care Absolute Neutrophil Count in Suspected Neutropenic Fever (DUCATIS) - Diagnostic Accuracy (S1)Oct 28, 2026NCT07901660
- Improving Women's Fertility Awareness and Reducing Anxiety Through Ovarian Reserve Screening and AI CounselingOct 26, 2026NCT07894302
- Oculomotor-Pupillary AI Biomarkers in Parkinson'sOct 21, 2026NCT07886450
- Acceptance-based Self-care Intervention for Older Adults With MultimorbidityOct 20, 2026NCT07882992
- Home-Based Exercise and Vagus Nerve Stimulation for Chemotherapy-Induced NeuropathyOct 16, 2026NCT07877558
- Histotripsy x Pancreatic CancerOct 14, 2026NCT07873606
- Histotripsy for Peritoneal Tumour and Lymph Node: a Pilot StudyOct 14, 2026NCT07873619
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasEOct 14, 2026NCT07874139
- Effects of Home-based CIMT and Clinic-based CIM on StrokeOct 13, 2026NCT06465251
- Evaluate of the Use of Uromune as a Potential Non-antibiotic Prophylactic Strategy for Catheter-associated Urinary Tract Infection in Patients With Long-term Catheterization.Oct 13, 2026NCT07869992
Studies
Recruiting first, then most recently updated. Showing 50 of 4,796 — search for more.
- A Nurse-led Structured Risk Factor Management Programme to Improve Quality of Life for Patients With Atrial FibrillationNot yet recruitingNCT07929259Not applicable
- A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)RecruitingNCT06351631Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With ASDRecruitingNCT05492032Not applicable
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingNCT06717347Phase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RecruitingNCT07252739Phase 2
- MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)RecruitingNCT07431827Phase 3
- A Mechanism Randomised Controlled Trial of a Three-Agent LLM-Augmented mHealth Intervention for Late-Life Loneliness in Older AdultsRecruitingNCT07822828Not applicable
- Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease ManagementRecruitingNCT07842536Not applicable
- Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGDRecruitingNCT06220474Not applicable
- Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)RecruitingNCT06711887Phase 3
- 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal KeratoconjunctivitisRecruitingNCT06903884Phase 3
- Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI PerfusionRecruitingNCT07068399Not applicable
- A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Steatotic Liver DiseaseRecruitingNCT07450144Not applicable
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07541170Phase 3
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusRecruitingNCT07775404Phase 3
- Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 WeeksRecruitingNCT07816328Phase 3
- Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's DiseaseNot yet recruitingNCT07779863Not applicable
- Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: Selective Trunk Block vs Supraclavicular Brachial Plexus BlockRecruitingNCT05649644Not applicable
- Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD AdolescentsRecruitingNCT06272669Not applicable
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 2
- Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve BlockRecruitingNCT04397484Phase 4
- Minimum Effective Local Anesthetic Volume for Ultrasound Guided Superior Trunk BlockRecruitingNCT04941664Not applicable
- A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer: The VIOLETTA TrialRecruitingNCT06262633Not applicable
- SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein ThrombosisRecruitingNCT06823375Phase 2
- ITPB 1 vs 3 in VATSRecruitingNCT06838793Not applicable
- Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal CancerRecruitingNCT06029270Phase 2
- Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)RecruitingNCT06881784Phase 3
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RecruitingNCT05920356Phase 3
- WATER IV PCa (AS Sub-study)RecruitingNCT07650448Not applicable
- A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung CancerRecruitingNCT07699328Phase 1/2
- Exercise to Improve Heart and Metabolic Health After Childbirth in Women at High Risk for PreeclampsiaRecruitingNCT07921173Not applicable
- Multi-center Study of Three-Dimensional Transesophageal Echocardiography in Patients With Secondary Mitral RegurgitationNot yet recruitingNCT07918937
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)RecruitingNCT06393374Phase 3
- Pilot Project on Enhancing Support for Hidden Elderly in the Three-nil Buildings and Old Tenement Buildings: Capacity Building & Impact EvaluationNot yet recruitingNCT07920328Not applicable
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)RecruitingNCT06136624Phase 3
- Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationRecruitingNCT05315700Phase 1/2
- A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerRecruitingNCT06793215Phase 3
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerRecruitingNCT06982521Phase 3
- An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell LymphomaRecruitingNCT07200375
- A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)RecruitingNCT07361497Phase 3
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)RecruitingNCT07220083Phase 3
- A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)RecruitingNCT07549412Phase 3
- Comprehensive Clinical Prediction Rule for Acute Heart FailureRecruitingNCT07754084